Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Pros and Cons of All-Case PMS Presented: SJP Seminar
October 9, 2006
- BUSINESS NEWS IN BRIEF
October 2, 2006
- MEDICAL DEVICE NEWS IN BRIEF
October 2, 2006
- SEMINAR Users' Complaints Are Gold Mines: Dr Tsuji of J&T Institute
October 2, 2006
- General Assembly of Med. Association-Operated Med. Facilities
October 2, 2006
- TOPICS GSK Opens Website on Blepharospasms,Hemifacial Spasms, Spasmodic Torticollis
October 2, 2006
- Med. Institutions Claiming Nicotine Dependence Management Fee Show Large Increase
October 2, 2006
- 200 Applications Received to Align Indications with Original Products
October 2, 2006
- Reducing Average Length of Hospital Stay Essential: Vice Minister
October 2, 2006
- Taiyo Pharm. Completes Seamless Production Line for Prefilled Syringes
October 2, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 2, 2006
- Wholesalers Must Offer Well-Grounded Prices: Korosho Hearing
October 2, 2006
- Novartis, Daiichi Sankyo to Terminate Agreement for Lamisil AT, Nicotinel TTS
October 2, 2006
- Inter-ministerial Efforts Accelerated to Promote Life Science
October 2, 2006
- SSP to Launch CHOLESTEGUARD to Fight High Cholesterol
October 2, 2006
- Barcode Labering Requirements Annouced
October 2, 2006
- Industry Seeks to Bring About Gov't-Industry Dialogue: JPMA Policy Seminar
October 2, 2006
- New Head of PFSB Outlines Bureau's Plans at Press Conference
October 2, 2006
- REGULATORY NEWS IN BRIEF
October 2, 2006
- IMMD Completes PI Clinical Trial of IMD-0354
October 2, 2006
ページ
Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…